CytomX Therapeutics Inc is a clinical-stage, oncology-focused biopharmaceutical company that develops novel conditionally activated, masked biologics designed to target the tumor microenvironment. The company serves the oncology market with therapeutic candidates in various modalities, including antibody-drug conjugates, T-cell engagers, and immune modulators.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.